What would be your recommendation for treatment of worsening lung disease in a patient with long-standing scleroderma after long-term mycophenolate therapy which is no longer an option due to side effect/intolerance?
3 Answers
Mednet Member
Rheumatology · Georgetown University Medical Center
Someone who has been on long-term Mycophenolate for interstitial lung disease and has had stabilization or improvement in their lung function and then is unable to tolerate the medication may be able to be switched to mycophenolic acid sodium (myfortic) which is often less toxic and better able to b...
Mednet Member
Rheumatology · Brookdale University Hospital Medical Center
In the setting of progressive disease despite mycophenolate and Rituximab, you can also try monthly IVIG.